October 18, 2012 ·
Leave a comment
October 18, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement focused on medical centers of excellence in obesity with a top U. S. biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating the condition of obesity, approached Thought Leader Select for support with a variety of collaborative efforts, including medical science liaison outreach to leading universities, medical schools, teaching hospitals, and specialty clinics in this area. Having already worked with Thought Leader Select to form rosters of key opinion leaders in endocrinology, primary care, nursing, pharmacy, and long-term care in the treatment of type I and type II diabetes and obesity, the company has now chosen Thought Leader Select to pinpoint the leading centers of excellence in the treatment of obesity in the United States.
Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will assess the skills and experience of selected centers, detailing the collaborative activities of leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, the people who advance the science of medicine and patient care, through basic and clinical research, scientific journal ... read more »
TAGS: 
basic research biopharmaceutical industry biotechnology Brian Castle centers of excellence identification centers of excellence profiling centers of excellence strategy clinical pharmacists clinical research drug development endocrinology health care professionals key opinion leaders KOL identification KOL profiling KOL strategy long-term care medical device industry medical diagnostics medical researchers medical schools medical science medical science liaison outreach nursing obesity obesity centers of excellence obesity KOLs patient care pharmaceuticals pharmacy physician assistants physicians primary care medicine registered nurses scientific journal publishing specialty medical clinics teaching hospitals Thought Leader Select Thought Leader Select consulting group Thought Leader Select research group treatment guidelines type 1 diatbetes type 2 diabetes universities
February 2, 2012 ·
Leave a comment
New Press Release from the Offices of Thought Leader Select
February 2, 2012 (Chapel Hill, NC) Thought Leader Select is pleased to announce a pair of key opinion leader (KOL) identification and profiling projects to support the development pipeline of a leading pharmaceutical client focused in the therapeutic area of gastroenterology.
In the first research assessment, Thought Leader Select will identify and profile leading medical experts in the treatment of patients suffering from non-cancer-related chronic pain. The company will identify the leading pain experts throughout the United States by examining the skills and experiences of physicians in multiple disciplines and specialties, including gastroenterologists, primary care physicians, nurse practitioners, and physician assistants.
For the second research assessment, Thought Leader Select will identify and profile 100 key opinion leaders in colorectal surgery, as well as 125 KOLs in gastroenterology. The cumulative group of 225 physician thought leaders will share vast experience in research and treatment of fecal incontinence.
Thought Leader Select will use its validated, objective deep profiling methodology to assess the skills and experience of the thought leaders chronic pain, colorectal surgery, and gastroenterology in multiple research categories, including their areas of expertise, medical/scientific journal publishing history, and participation in basic and clinical research. The company’s research group is comprised of subject-matter experts in medicine, with decades of experience working in ... read more »
TAGS: basic and clinical research chronic pain clinical research colorectal surgery deep-profiling drug development pipeline gastroenterology key opinion leaders KOL late-stage clinical trials medical experts medical research medicine nurse practitioners patient treatment Paul Meade pharmaceuticals physician assistants physicians primary care physicians publishing scientific advisory boards scientific journals therapeutic area Thought Leader Select thought leaders
January 12, 2012 ·
Leave a comment
By Brian Castle and Kristen Smithwick
When most people think about thought leaders in medicine, specialists in oncology, neurology, rheumatology and other therapeutic areas immediately come to mind. However, with the proliferation of illnesses and conditions ranging from diabetes and obesity to asthma, gastrointestinal diseases and psychiatric disorders, key opinion leaders in primary care and allied health professions are more important than ever.
In addition to the growing incidence of several “lifestyle” conditions, the structure of U.S. healthcare dictates that people suffering in these areas see their primary care physicians (PCPs), nurses, nurse practitioners, physician assistants, and pharmacists with much greater frequency than their specialists. As a result, more PCPs and allied health professionals are joining their specialist colleagues in all of the critical areas that define thought leadership, including publishing, basic and clinical research, clinical practice, speaking, and advocacy involvement.
Thought Leader Select has conducted multiple assessments of thought leader populations in a variety of therapeutic areas, with particular attention to the impact of PCPs, also known as general practitioners, in areas of treatment as diverse as diabetes, allergies, infectious disease, and gastrointestinal conditions. Primary care physicians, along with their nurse practitioner (NP), physician assistant (PA), and registered nurse colleagues, consistently distinguish themselves in many of the traditional areas of thought leadership once assumed to be the domain of specialists and sub-specialists.
Leaders ... read more » TAGS: allergies allied health professions. asthma clinical practice clinical research co-investigator community disease awareness events diabetes disease task force diseases gastrointestinal grand rounds HCPs Hepatitis C hepatology HIV illnesses indigent populations infectious disease irritable bowel syndrome key opinion leaders lifestyle conditions lobbying medical conferences medical congresses medical research National Cancer Institute NCI neurology nurse practitioners obesity Oncology patient advocacy patient support PCPs pharmacists physician assistants physicians primary care psychiatric registered nurses rheumatology support groups Thought Leader Select thought leaders thought leadership US healthcare
March 23, 2011 ·
Leave a comment
March 23, 2011 (CHAPEL HILL, NC)—Thought Leader Select, a research and consulting firm focused on healthcare and the biopharmaceutical industry, has initiated its most comprehensive package of research assessments in support of a new dermatology medication for a global pharmaceutical company.
The Research Triangle, NC-based firm packaged together a host of its competitive services for assessing the skills and experiences of the medical community. These company’s research and advisory services will provide a foundation for collaborations in support of a new treatment for pre-cancerous skin growths and other dermatological conditions. In one comprehensive project, Thought Leader Select will deliver assessments of more than 65 core physician thought leaders and emerging key opinion leaders in the allied health professions (including nurses, physician assistants, and nurse practitioners), and medical centers of excellence in dermatology. In addition, Thought Leader Select will also assess and engage experts in market access and reimbursement. The firm will deliver its findings through its proprietary database, Thought Leader Index, and will also support medical, clinical, and brand teams with both technology and advisory services.
“We are very excited to be helping a new client in so many ways,” stated Neil Mellor, business development consultant at Thought Leader Select. “This is the most comprehensive project we’ve ever done at Thought Leader Select—it’s showing our ability to really customize to meet the ... read more »
TAGS: advisory services allied health professions. biopharmaceutical client customize dermatological conditions dermatology medication global pharmaceutical company health professions healthcare key opinion leaders KOL identification market access medical centers of excellence medical community Neil Mellor new treatment nurse practitioners nurses physician assistants physician thought leaders pre-cancerous skin growths profiling reimbursement research assessment rising stars Thought Leader Index Thought Leader Select
February 3, 2011 ·
Leave a comment
New press release out today from the offices of Thought Leader Select:
Thought Leader Select announces 50 Percent Annual Growth for 2010
FOR IMMEDIATE RELEASE
February 3, 2010 (CHAPEL HILL, NC)-Thought Leader Select, a Research Triangle, NC-based research and consulting company serving the biopharmaceutical and healthcare industries, announces 50 percent year-over-year growth for 2010.
Founded in 2006, Thought Leader Select is a specialty firm dedicated to strengthening industry collaborations with medical experts for the development of next generation medicines. The company’s practice area focuses on three aspects of working with key opinion leaders (KOLs) in the medical community: identification and profiling, mapping, and engagement.
During the 2010 fiscal year, the company grew its revenues by 50 percent over fiscal year 2009, according to Kristen Smithwick, Vice President of Business Development, Marketing, and Strategic Planning. “We had a very strong year in 2010, and we have solidified our position as one of the preeminent thought leader engagement companies in the marketplace,” stated Smithwick.
The company marked 2010 by generating a record 28 customized research assessments for 10 of the top 50 global biopharmaceutical companies (measured by revenue). Thought Leader Select identified and profiled over 2500 KOLs in 30 countries. The medical experts represented multiple therapeutic areas and disease states, including neurology, ophthalmology, cardiology, endocrinology, and immunology.
Thought Leader Select used its industry-leading “deep profiling” methodology to ... read more »
TAGS: biopharmaceutical cardiology certified diabetes educators Clarissa Noureddine consulting company deep-profiling endocrinology engagement healthcare identification immunology key opinion leaders KOLs Kristen Smithwick mapping medical experts medical researchers medicine neurology nurse practitioners ophthalmology physician assistants physicians profiling reimbursement research assessments Research Triangle
November 4, 2010 ·
Leave a comment
Neil Mellor, business development consultant at Thought Leader Select, and Paul Meade, the company’s president and founder, attended SMi’s KOL: Knowledge Leader Partnerships conference on September 29 and 30 in London. Neil sat down with the Thought Leader Select Blog to discuss his takeaways from the conference.
TLS Blog: Neil, how was the conference in London?
Neil Mellor: I found it quite interesting, and so did Paul—since we’ve grown the company over the last five years to include multiple European and global thought leader assessments, we thought it made sense to get a real sense of the industry’s thinking about what we do on the European continent.
TLS Blog: What were some of the main points of discussion?
Neil Mellor: Right now, there’s a pretty hot debate going on about the roles that health care professionals play in the development and launch of new medicines. This conference even included a robust discussion on what to call them—it seems the European marketplace is evolving away from the term “key opinion leader,” with companies choosing instead to rely on what they call “external experts,” “opinion leaders,” or “thought leaders.” It made us feel even better about the name of our company, that’s for sure!
TLS Blog: Would you say that there’s a migration going on in the perception of the HCPs ... read more »
TAGS: allied health professionals biopharmaceutical biotech British Medical Journal clinical practice Dr. Fiona Godlee external experts FDA HCP health care professionals key opinion leader Knowledge Leader Partnerships Conference London medical experts Neil Mellor new medicines nurse practitioners opinion leaders patient Paul Meade pharma pharmacists physician assistants public health publishing registered nurses research SMi Sunshine Act therapeutic area thought leader assessments Thought Leader Select thought leaders
June 9, 2010 ·
Leave a comment
Cammie Brannan joined Clear Point Health and Thought Leader Select as a research associate in 2005. In her current role managing thought leader relations at Thought Leader Select, Cammie works directly with physicians and other health care professionals to ensure the accuracy and integrity of the data for each key opinion leader assessment. Cammie spent a decade working in accounting and financial management, earning a reputation as a leader in compiling data and optimizing its presentation for decision-makers in a variety of industries. Prior to joining Thought Leader Select, Cammie worked for a North Carolina firm that provided research and consulting services to the pharmaceutical industry, with emphasis on the drug-naming process.
The Thought Leader Select Blog sat down with Cammie to discuss her industry experience and her professional contribution to Thought Leader Select.
TLS Blog: Good morning, Cammie. Why did you join Thought Leader Select?
Cammie Brannan: I had been doing contract market research for a company in Raleigh, NC. We specialized in all of the aspects of naming new pharmaceutical products—market research, market testing, etc. I interacted quite a bit with health care professionals—we surveyed them.—gaining their valuable feedback on potential new names for drugs. For instance, were the names appealing, memorable, and would they be confused with other products on the market. It was a pretty interesting business.
While I was ... read more »
TAGS: accounting Asperger's syndrome biotechnology Cammie Brannan Clear Point Health data optimization drug naming financial planning fishing health care professionals key opinion leaders KOL engagement KOL identification KOL profiling KOLs Laura Nufire Lisa Smith medical ethics medical experts music nurse practitioners nurses Paul Meade pharmaceutical physician assistants physicians research surveying thought leader relations Thought Leader Select thought leaders transparency
June 1, 2010 ·
Leave a comment
In a recent post on Pharmalot, the pharmaceutical industry blog highlighted a recent survey that gauged American opinions on the speed and safety of the process for developing new medicines. The survey, conducted by Eli Lilly and ResearchAmerica, measured a number of opinions Americans hold regarding the pharmaceutical industry and the FDA itself.
While over 70 per cent of the respondents trust the FDA approval process for new drugs, more than half say the process should be faster. The most stunning numbers in the survey come from the questions regarding industry collaborations with universities and the government. Ninety-four per cent of the respondents said that pharmaceutical companies, universities, and the government should work together to develop new medicines more quickly and safely, and 88 per cent said that it was a good idea for drug companies to collaborate with hospitals, universities, and other health institutions.
The Lilly/Research America survey gives even more weight, the weight of public opinion,that the pharmaceutical industry must continue to increase its collaborations with medical experts to ensure that new medicines are delivered safely and in a timely fashion. Working with the right experts at the right points of development can save millions of dollars in development costs, and, more importantly, save more lives.
At Thought Leader Select, the collaborative synergy of the pharmaceutical industry and medical experts ... read more »
TAGS: Americans clinical research clinical trials drug development drug discovery Eli Lilly ethics FDA Food and Drug Administration government agencies health survey key opinion leaders KOL engagement KOL identification KOL profiling KOLs medical researchers nurse practitioners Pharmalot physician assistants physicians regulatory/reimbursement specialists ResearchAmerica researchers Thought Leader Select thought leaders transparcency
May 11, 2010 ·
Leave a comment
May 11, 2010 (CHAPEL HILL, NC) Paul Meade, founder and president of Thought Leader Select, a North Carolina firm dedicated to key opinion leader (KOL) development solutions for the biopharmaceutical industry, received a master of public health degree from the University of North Carolina at Chapel Hill on May 8, 2010.
The Gillings School of Global Public Health at UNC awarded Meade, a 25-year veteran of the pharmaceutical industry, with a master of public health degree and a certificate in public health ethics in the Public Health Leadership Program. Meade’s research report, “How Volunteer Community Organizations Can Assist State Public Health Departments During Pandemic Influenza,” explored specific possibilities for the Civil Air Patrol, a volunteer non-profit national organization and an auxiliary of the United States Air Force, to assist state public health officials during widespread outbreaks of influenza.
The master of public health degree is Meade’s second master’s degree. He earned a master of science in biomedical science from the University of Guelph (Canada) in 1977, following his bachelor of science degree in biology and chemistry from Acadia University (Canada) in 1971.
During his 25-year career in the pharmaceutical industry, Meade served in a variety of leadership positions at Merck and GlaxoSmithKline. During his ten years at Merck, Meade worked his way from a sales representative position to director of marketing planning for ... read more »
TAGS: biopharmaceutical biotechnology certificate Civil Air Patrol Clear Point Health clinical operations clinical researchers Gillings School of Global Public Health GlaxoSmithKline healthcare ethics healthcare policy healthcare research key opinion leaders KOL deployment KOL development KOL engagement KOL identification KOL profiling KOLs marketing planning master of public health medical affairs Merck nurses Paul Meade pharmaceutical pharmacists physician assistants physicians predictive medicine public health ethics Public Health Leadership Program research and development Thought Leader Select United States Air Force University of North Carolina at Chapel Hill veterinarians
April 14, 2010 ·
Leave a comment
April 15, 2010 (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina-based firm dedicated to delivering solutions for key opinion leader (KOL) management for the biopharmaceutical industry, has announced the delivery of KOL identification projects for five leading North American pharmaceutical companies during the first quarter of 2010.
Five of the world’s largest pharmaceutical concerns contracted with Thought Leader Select in late 2009 to take advantage of the firm’s industry-leading deep profiling methodology for researching the skills and experiences of physician key opinion leaders across multiple therapeutic areas and disease states. Each company had specialized needs for initiation and redevelopment of their respective rosters of key opinion leaders to assist them in a variety of deployment needs.
Thought Leader Select assisted a Canadian firm with the identification of physician key opinion leaders who specialize in influenza vaccines. The company plans to build a firm roster of KOLs in advance of a new influenza vaccine product launch.
A U.S. firm contracted Thought Leader Select to identify nurse practitioners and physician assistants, also known as non-traditional KOLs, in the therapeutic areas of gastroenterology, hepatology, and HIV/AIDS treatment, in order to better understand patient needs in these areas and gain scientific and clinical insights for new compounds.
Thought Leader Select identified Canadian physician key opinion leaders for another Canadian company, with emphasis on KOLs who specialize in heart ... read more »
TAGS: biotechnology cardiology clinical investigators deep-profiling disease states gastroenterology general surgery heart failure hemophilia hepatology HIV/AIDS hypertension influenza vaccines key opinion leader KOL identification KOL management KOL research Kristen Smithwick new compounds non-traditional key opinion leaders nurse practitioners ortho-spine surgery orthopaedic surgery pharmaceutical physician assistants physicians post-MI congestive heart failure therapeutic areas Thought Leader Select
